Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Rang în acțiuni #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Preț acțiune
$0.117
Ultima sincronizare: 2025-04-04
Capitalizare de piață
$2.45M
Schimbare (1 zi)
-13.59%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Carmell Therapeutics Corporation (CTCX)

Categorie

EPS pentru Carmell Therapeutics Corporation (CTCX)
EPS la data de June 2026 TTM: $-4.71
Conform celor mai recente rapoarte financiare și prețului acțiunilor Carmell Therapeutics Corporation, EPS-ul actual al companiei (TTM) este $-4.71. La sfârșitul anului 2023, compania avea un EPS de $-0.74 o creștere față de EPS-ului din 2022, care a fost de $-0.50.
Istoricul EPS pentru Carmell Therapeutics Corporation din 2021 până în 2026
EPS la sfârșitul fiecărui an
An EPS Schimbă
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
EPS pentru companii similare sau concurente
Companie EPS Diferență EPS Țara
$17.32 -467.73%
US
$27.74 -688.96%
NL
- -
CH
- -
KR
$13.70 -390.87%
BE